Noveris Health Sciences is trading at CA$0.29 (-10.77%), with no clear cause identified for the decline.

  • No new company-specific announcement or confirmed catalyst was identified for August 13, 2026.
  • The decline extends a highly volatile selloff following losses on August 11 and August 12, despite generally stronger broader-market sentiment.
  • On August 6, management stated it was unaware of any material change explaining unusual market activity.